Intangible Assets, Net (Excluding Goodwill) of VBI Vaccines Inc/BC from 31 Dec 2015 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
VBI Vaccines Inc/BC quarterly Intangible Assets, Net (Excluding Goodwill) in USD history and change rate from 31 Dec 2015 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Intangible Assets, Net (Excluding Goodwill) for the quarter ending 31 Mar 2024 was $35,734,000, a 39% decline year-over-year.
Source SEC data
View on sec.gov
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Intangible Assets, Net (Excluding Goodwill) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $35,734,000 -$22,766,000 -39% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $36,499,000 -$21,846,000 -37% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 $35,603,000 -$22,124,000 -38% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $40,339,000 -$21,040,000 -34% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $58,500,000 -$4,718,000 -7.5% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $58,345,000 -$3,746,000 -6% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $57,727,000 -$4,423,000 -7.1% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $61,379,000 -$2,489,000 -3.9% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $63,218,000 +$482,000 +0.77% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $62,091,000 -$65,000 -0.1% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $62,150,000 +$2,982,000 +5% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $63,868,000 +$5,859,000 +10% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $62,736,000 +$6,818,000 +12% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $62,156,000 +$1,400,000 +2.3% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $59,168,000 -$741,000 -1.2% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $58,009,000 -$2,581,000 -4.3% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $55,918,000 -$3,547,000 -6% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $60,756,000 +$2,507,000 +4.3% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $59,909,000 -$1,622,000 -2.6% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $60,590,000 +$216,000 +0.36% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $59,465,000 -$2,135,000 -3.5% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $58,249,000 -$5,087,000 -8% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 $61,531,000 -$2,138,000 -3.4% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $60,374,000 -$1,158,000 -1.9% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $61,600,000 +$1,623,000 +2.7% 31 Mar 2018 10-Q 01 May 2018 2018 Q1
Q4 2017 $63,336,000 +$3,829,000 +6.4% 31 Dec 2017 10-K 25 Feb 2019 2018 FY
Q3 2017 $63,669,000 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $61,532,000 30 Jun 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 $59,977,000 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $59,507,000 +$59,121,000 +15316% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q4 2015 $386,000 31 Dec 2015 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.